Testing effectiveness (Phase 2)Not Yet RecruitingNCT07303283
What this trial is testing
Becotatug Vedotin as Adjuvant Therapy For High-risk Nasopharyngeal Carcinoma
Who this might be right for
Nasopharyngeal Carcinoma (NPC)Locoregionally Advanced Nasopharyngeal CarcinomaAdjuvant Therapy
Kai Hu 140